Cargando…

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question

PURPOSE: Whether or not androgen receptor (AR) axis could still be targetable in castration resistant prostate cancer (CRPC) patients with disease progression to next generation hormonal agents (NGHAs) is a controversial issue. RESULTS: Serum testosterone in CRPC patients has a positive prognostic r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caramella, Irene, Dalla Volta, Alberto, Bergamini, Marco, Cosentini, Deborah, Valcamonico, Francesca, Berruti, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637055/ https://www.ncbi.nlm.nih.gov/pubmed/35986139 http://dx.doi.org/10.1007/s12020-022-03166-w

Ejemplares similares

Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients
por: Dalla Volta, Alberto, et al.
Publicado: (2023)

Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
por: Bergamini, Marco, et al.
Publicado: (2022)

Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?
por: Grisanti, Salvatore, et al.
Publicado: (2021)

Immunotherapy failure in adrenocortical cancer: where next?
por: Cosentini, Deborah, et al.
Publicado: (2018)

Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy
por: Cosentini, Deborah, et al.
Publicado: (2021)

Deworming and Development: Asking the Right Questions, Asking the Questions Right
por: Bundy, Donald A. P., et al.
Publicado: (2009)

How do we define “castration” in men on androgen deprivation therapy?
por: Itty, Sarin, et al.
Publicado: (2020)

In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions?
por: Hall, Deborah A.
Publicado: (2014)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012)

COVID-19: Obesity, deprivation and death
por: Simpson, A Hamish RW, et al.
Publicado: (2020)

A Novel Liver-targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men With Prostate Cancer
por: Rhee, Handoo, et al.
Publicado: (2021)

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

Cardiometabolic Complications after Androgen Deprivation Therapy in a Man with Prostate Cancer: Effects of 3 Years Intermittent Testosterone Supplementation
por: Aversa, Antonio, et al.
Publicado: (2012)

CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
por: Joshi, Molishree, et al.
Publicado: (2019)

Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer
por: Liu, Junjiang, et al.
Publicado: (2022)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

To research (or not) that is the question: ethical issues in research when medical care is disrupted by political action: a case study from Eldoret, Kenya
por: House, Darlene R, et al.
Publicado: (2016)

Telehealth Regulatory and Legal Considerations: Frequently Asked Questions
por: Cason, Jana, et al.
Publicado: (2011)

The Problem of Questionable Dystonia in the Diagnosis of ‘Essential Tremor-Plus’
por: Pandey, Sanjay, et al.
Publicado: (2020)

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
por: Grisanti, Salvatore, et al.
Publicado: (2021)

Platelet-Rich Plasma in Androgenic Alopecia: Myth or an Effective Tool
por: Khatu, Swapna S, et al.
Publicado: (2014)

Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
por: Amore, Mario, et al.
Publicado: (2012)

Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer
por: Nam, Wook, et al.
Publicado: (2018)

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
por: Hussain, Arif, et al.
Publicado: (2020)

Erythropoietin in the critically ill: do we ask the right questions?
por: McCook, Oscar, et al.
Publicado: (2012)

Intersecting HIV and mpox epidemics: more questions than answers
por: Girometti, Nicolo, et al.
Publicado: (2022)

Endoscopic ultrasound (EUS) or endoscopic retrograde cholangiopancreatography (ERCP): is that the question?
por: Feng, Yunlu, et al.
Publicado: (2022)

New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours
por: Iggo, Richard D
Publicado: (2011)

Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study
por: Palumbo, Carlotta, et al.
Publicado: (2021)

Unrecognized Kinetics of Serum Testosterone: Impact on Short-Term Androgen Deprivation Therapy for Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2014)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
por: Salciccia, Stefano, et al.
Publicado: (2020)

Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model
por: Borque-Fernando, Ángel, et al.
Publicado: (2023)

When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients
por: Foroni, Chiara, et al.
Publicado: (2020)

Sleep deprivation and starvation in hospitalised patients: how medical care can harm patients
por: Xu, Tim, et al.
Publicado: (2016)

Cutaneous Manifestations of Anabolic-Androgenic Steroid Use in Bodybuilders and the Dermatologist’s Role in Patient Care
por: Furth, Garrett, et al.
Publicado: (2023)

Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers
por: Beran, David, et al.
Publicado: (2017)

National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment
por: Parmar, Arpit, et al.
Publicado: (2020)

SARS-CoV-2 and COVID-19: revisiting the most important research questions
por: Yuen, Kit-San, et al.
Publicado: (2021)

The vulnerable and the susceptible: The weight of evidenza to stop exploiting activities generating toxic exposures in unprotected and deprived countries
por: Frazzoli, Chiara
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jpfu9j6evkmbcd101nv6e4cgg